Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

IgM in human immunity to Plasmodium falciparum malaria.

Boyle MJ, Chan JA, Handayuni I, Reiling L, Feng G, Hilton A, Kurtovic L, Oyong D, Piera KA, Barber BE, William T, Eisen DP, Minigo G, Langer C, Drew DR, de Labastida Rivera F, Amante FH, Williams TN, Kinyanjui S, Marsh K, Doolan DL, Engwerda C, Fowkes FJI, Grigg MJ, Mueller I, McCarthy JS, Anstey NM, Beeson JG.

Sci Adv. 2019 Sep 25;5(9):eaax4489. doi: 10.1126/sciadv.aax4489. eCollection 2019 Sep.

2.

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.

Chan JA, Wetzel D, Reiling L, Miura K, Drew DR, Gilson PR, Anderson DA, Richards JS, Long CA, Suckow M, Jenzelewski V, Tsuboi T, Boyle MJ, Piontek M, Beeson JG.

PLoS One. 2019 Sep 10;14(9):e0221733. doi: 10.1371/journal.pone.0221733. eCollection 2019.

3.

Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier.

Goodall EF, Leach V, Wang C, Cooper-Knock J, Heath PR, Baker D, Drew DR, Saffrey MJ, Simpson JE, Romero IA, Wharton SB.

Int J Mol Sci. 2019 Jun 25;20(12). pii: E3097. doi: 10.3390/ijms20123097.

4.

Induction and decay of functional complement-fixing antibodies by the RTS,S malaria vaccine in children, and a negative impact of malaria exposure.

Kurtovic L, Agius PA, Feng G, Drew DR, Ubillos I, Sacarlal J, Aponte JJ, Fowkes FJI, Dobaño C, Beeson JG.

BMC Med. 2019 Feb 25;17(1):45. doi: 10.1186/s12916-019-1277-x.

5.

Low Levels of Human Antibodies to Gametocyte-Infected Erythrocytes Contrasts the PfEMP1-Dominant Response to Asexual Stages in P. falciparum Malaria.

Chan JA, Drew DR, Reiling L, Lisboa-Pinto A, Dinko B, Sutherland CJ, Dent AE, Chelimo K, Kazura JW, Boyle MJ, Beeson JG.

Front Immunol. 2019 Jan 14;9:3126. doi: 10.3389/fimmu.2018.03126. eCollection 2018.

6.

Cellular dissection of malaria parasite invasion of human erythrocytes using viable Plasmodium knowlesi merozoites.

Lyth O, Vizcay-Barrena G, Wright KE, Haase S, Mohring F, Najer A, Henshall IG, Ashdown GW, Bannister LH, Drew DR, Beeson JG, Fleck RA, Moon RW, Wilson DW, Baum J.

Sci Rep. 2018 Jul 5;8(1):10165. doi: 10.1038/s41598-018-28457-z.

7.

Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development.

Drew DR, Sanders PR, Weiss G, Gilson PR, Crabb BS, Beeson JG.

J Infect Dis. 2018 Jan 17;217(3):498-507. doi: 10.1093/infdis/jix583.

PMID:
29165651
8.

Age-associated changes in the blood-brain barrier: comparative studies in human and mouse.

Goodall EF, Wang C, Simpson JE, Baker DJ, Drew DR, Heath PR, Saffrey MJ, Romero IA, Wharton SB.

Neuropathol Appl Neurobiol. 2018 Apr;44(3):328-340. doi: 10.1111/nan.12408. Epub 2017 May 29. Erratum in: Neuropathol Appl Neurobiol. 2018 Dec;44(7):747-748.

9.

Truncated Latrunculins as Actin Inhibitors Targeting Plasmodium falciparum Motility and Host Cell Invasion.

Johnson S, Rahmani R, Drew DR, Williams MJ, Wilkinson M, Tan YH, Huang JX, Tonkin CJ, Beeson JG, Baum J, Smith BJ, Baell JB.

J Med Chem. 2016 Dec 22;59(24):10994-11005. doi: 10.1021/acs.jmedchem.6b01109. Epub 2016 Dec 2.

10.

A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens.

Drew DR, Wilson DW, Elliott SR, Cross N, Terheggen U, Hodder AN, Siba PM, Chelimo K, Dent AE, Kazura JW, Mueller I, Beeson JG.

BMC Med. 2016 Sep 23;14(1):144.

11.

The association between naturally acquired IgG subclass specific antibodies to the PfRH5 invasion complex and protection from Plasmodium falciparum malaria.

Weaver R, Reiling L, Feng G, Drew DR, Mueller I, Siba PM, Tsuboi T, Richards JS, Fowkes FJI, Beeson JG.

Sci Rep. 2016 Sep 8;6:33094. doi: 10.1038/srep33094.

12.

Structure-Activity Studies of β-Hairpin Peptide Inhibitors of the Plasmodium falciparum AMA1-RON2 Interaction.

Wang G, Drinkwater N, Drew DR, MacRaild CA, Chalmers DK, Mohanty B, Lim SS, Anders RF, Beeson JG, Thompson PE, McGowan S, Simpson JS, Norton RS, Scanlon MJ.

J Mol Biol. 2016 Oct 9;428(20):3986-3998. doi: 10.1016/j.jmb.2016.07.001. Epub 2016 Jul 14.

PMID:
27422009
13.

Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria.

Beeson JG, Drew DR, Boyle MJ, Feng G, Fowkes FJ, Richards JS.

FEMS Microbiol Rev. 2016 May;40(3):343-72. doi: 10.1093/femsre/fuw001. Epub 2016 Jan 31. Review.

14.

PfRH5 as a candidate vaccine for Plasmodium falciparum malaria.

Drew DR, Beeson JG.

Trends Parasitol. 2015 Mar;31(3):87-8. doi: 10.1016/j.pt.2015.02.001. Epub 2015 Feb 19.

PMID:
25704640
15.

Research priorities for the development and implementation of serological tools for malaria surveillance.

Elliott SR, Fowkes FJ, Richards JS, Reiling L, Drew DR, Beeson JG.

F1000Prime Rep. 2014 Nov 4;6:100. doi: 10.12703/P6-100. eCollection 2014. Review.

16.

Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.

Terheggen U, Drew DR, Hodder AN, Cross NJ, Mugyenyi CK, Barry AE, Anders RF, Dutta S, Osier FH, Elliott SR, Senn N, Stanisic DI, Marsh K, Siba PM, Mueller I, Richards JS, Beeson JG.

BMC Med. 2014 Oct 16;12:183. doi: 10.1186/s12916-014-0183-5.

17.

Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.

Harris KS, Adda CG, Khore M, Drew DR, Valentini-Gatt A, Fowkes FJ, Beeson JG, Dutta S, Anders RF, Foley M.

Infect Immun. 2014 Nov;82(11):4707-17. doi: 10.1128/IAI.02061-14. Epub 2014 Aug 25.

18.

Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1.

Dutta S, Dlugosz LS, Drew DR, Ge X, Ababacar D, Rovira YI, Moch JK, Shi M, Long CA, Foley M, Beeson JG, Anders RF, Miura K, Haynes JD, Batchelor AH.

PLoS Pathog. 2013;9(12):e1003840. doi: 10.1371/journal.ppat.1003840. Epub 2013 Dec 26. Erratum in: PLoS Pathog. 2014 Jan;10(1). doi:10.1371/annotation/be0d67d1-314f-4654-8a2f-b668d1e32bbd. Ge, Xiopeng [corrected to Ge, Xiaopeng].

19.

Plasticity in transmission strategies of the malaria parasite, Plasmodium chabaudi: environmental and genetic effects.

Cameron A, Reece SE, Drew DR, Haydon DT, Yates AJ.

Evol Appl. 2013 Feb;6(2):365-76. doi: 10.1111/eva.12005. Epub 2012 Oct 10.

20.

Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria.

Drew DR, Hodder AN, Wilson DW, Foley M, Mueller I, Siba PM, Dent AE, Cowman AF, Beeson JG.

PLoS One. 2012;7(12):e51023. doi: 10.1371/journal.pone.0051023. Epub 2012 Dec 5.

21.

Competition and the evolution of reproductive restraint in malaria parasites.

Pollitt LC, Mideo N, Drew DR, Schneider P, Colegrave N, Reece SE.

Am Nat. 2011 Mar;177(3):358-67. doi: 10.1086/658175.

22.

Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites.

Huijben S, Nelson WA, Wargo AR, Sim DG, Drew DR, Read AF.

Evolution. 2010 Oct;64(10):2952-68. doi: 10.1111/j.1558-5646.2010.01068.x. Epub 2010 Aug 19.

23.

Sex ratio adjustment and kin discrimination in malaria parasites.

Reece SE, Drew DR, Gardner A.

Nature. 2008 May 29;453(7195):609-14. doi: 10.1038/nature06954.

24.

Truncation of Plasmodium berghei merozoite surface protein 8 does not affect in vivo blood-stage development.

de Koning-Ward TF, Drew DR, Chesson JM, Beeson JG, Crabb BS.

Mol Biochem Parasitol. 2008 May;159(1):69-72. doi: 10.1016/j.molbiopara.2008.01.005. Epub 2008 Feb 14.

PMID:
18359107
26.

Transmission stage investment of malaria parasites in response to in-host competition.

Wargo AR, de Roode JC, Huijben S, Drew DR, Read AF.

Proc Biol Sci. 2007 Oct 22;274(1625):2629-38.

27.

A set of glycosylphosphatidyl inositol-anchored membrane proteins of Plasmodium falciparum is refractory to genetic deletion.

Sanders PR, Kats LM, Drew DR, O'Donnell RA, O'Neill M, Maier AG, Coppel RL, Crabb BS.

Infect Immun. 2006 Jul;74(7):4330-8.

29.
30.

Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5.

Hodder AN, Drew DR, Epa VC, Delorenzi M, Bourgon R, Miller SK, Moritz RL, Frecklington DF, Simpson RJ, Speed TP, Pike RN, Crabb BS.

J Biol Chem. 2003 Nov 28;278(48):48169-77. Epub 2003 Sep 17.

31.

Molecular and genetic characterisation of the host-protective oncosphere antigens of taeniid cestode parasites.

Lightowlers MW, Gauci CG, Chow C, Drew DR, Gauci SM, Heath DD, Jackson DC, Dadley-Moore DL, Read AJ.

Int J Parasitol. 2003 Sep 30;33(11):1207-17. Review.

PMID:
13678636
32.

A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies.

de Koning-Ward TF, O'Donnell RA, Drew DR, Thomson R, Speed TP, Crabb BS.

J Exp Med. 2003 Sep 15;198(6):869-75. Epub 2003 Sep 8.

33.

A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle.

Miller SK, Good RT, Drew DR, Delorenzi M, Sanders PR, Hodder AN, Speed TP, Cowman AF, de Koning-Ward TF, Crabb BS.

J Biol Chem. 2002 Dec 6;277(49):47524-32. Epub 2002 Sep 11.

34.

Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine.

Webster DE, Cooney ML, Huang Z, Drew DR, Ramshaw IA, Dry IB, Strugnell RA, Martin JL, Wesselingh SL.

J Virol. 2002 Aug;76(15):7910-2.

35.

The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.

Drew DR, Boyle JS, Lew AM, Lightowlers MW, Chaplin PJ, Strugnell RA.

Vaccine. 2001 Aug 14;19(31):4417-28.

PMID:
11483267
36.

The human IgG3 hinge mediates the formation of antigen dimers that enhance humoral immune responses to DNA immunisation.

Drew DR, Boyle JS, Lew AM, Lightowlers MW, Strugnell RA.

Vaccine. 2001 Jul 20;19(30):4115-20.

PMID:
11457535
37.

A comparison of DNA vaccines expressing the 45W, 18k and 16k host-protective antigens of Taenia ovis in mice and sheep.

Drew DR, Lightowlers MW, Strugnell RA.

Vet Immunol Immunopathol. 2000 Oct 31;76(3-4):171-81.

PMID:
11044551
38.
39.
41.

Needle biopsy of the kidney.

BOHNE AW, ACKLES RC, DREW DR, URWILLER KL.

J Urol. 1958 Mar;79(3):393-6. No abstract available.

PMID:
13514895
42.

Needle biopsy of the kidney.

BOHNE AW, ACKLES RC, DREW DR, URWILLER KL.

Postgrad Semin Am Urol Assoc North Cent. 1957:76-8. No abstract available.

PMID:
13554409
43.

A comparative evaluation of intravenous pyelographic media.

BOHNE AW, DREW DR.

AMA Arch Surg. 1956 Dec;73(6):927-30. No abstract available.

PMID:
13372013
44.

A comparative clinical trial of urographic media: renografin, hypaque, and urokon.

EYLER WR, DREW DR, BOHNE AW.

Radiology. 1956 Jun;66(6):871-3. No abstract available.

PMID:
13323329

Supplemental Content

Support Center